Our results indicated that CSNK2B expression is frequently over-expressed in CRC tissues than in normal tissues, and CSNK2B promotes CRC cell proliferation in vitro and in vivo via activating the mTOR signaling pathway. This evidence concerns the gene MTOR and colorectal carcinoma.